ANDOVER, Mass. -- The threat of Severe Acute Respiratory Syndrome (SARS) has escalated the need for proper disinfection and cleaning measures to prevent further spread of the disease, according to Fiberlock Technologies, Inc., a leader in environmental bioscience technology.
While there are no SARS-specific products, the company today announced its ShockWave" sanitizer/disinfectant/cleaner concentrate meets interim guidelines for cleaning and disinfecting SARS patient environments, as outlined in a report recently issued by the Centers for Disease Control and Prevention (CDC).
According to the CDC report, only EPA-registered hospital detergent-disinfectants currently used by healthcare facilities for environmental sanitation may be used as cleaning and disinfectant agents. The report maintains that viruses with physical and biochemical properties similar to SARS are known to be readily inactivated by EPA-registered germicides, like ShockWave, that provide the proscribed level of disinfection during general use.
The CDC report suggests that daily cleaning by disinfectants such as Fiberlock's ShockWave should be considered a first line of defense for reducing the microbial burden caused by SARS exposure. ShockWave is a multipurpose, EPA-registered antimicrobial specially formulated for disinfecting hard, non-porous surfaces such as counters, floors, tiles and walls, as well as sanitizing porous and semi-porous materials including carpet, drywall and wood framing. The powerful, quaternary ammonium chloride blend has been tested to kill more than 80 pathogenic and environmental microbial organisms including E. coli, salmonella, HIV, hepatitis B, herpes, influenza, measles and poliovirus, among other strains.
With companies and facilities all around the world looking for methods to protect themselves and prevent further spread of this potentially deadly disease, we want to bring to light that ShockWave meets the strict interim guidelines set forth by the CDC and can be an important tool in maintaining the highest level of hygiene, says Cole Stanton, director of sales with Fiberlock. Surfaces in healthcare facilities, airports, schools and public venues that are exposed or touched frequently may serve as reservoirs of microbial contamination by SARS, and based on the CDC report, ShockWave may help reduce further transmission through its powerful cleaning, disinfecting and sanitizing capabilities.
A recent discovery by the Key Science and Technology Group under China s National Task Force for SARS Control and Prevention reveals that the SARS virus can live for up to 15 days outside of the human body (source: China Daily), making such daily cleaning practices critical to routine infection control.
ShockWave is available exclusively through select distributors in one-gallon jugs, yielding 64 gallons of usable product when diluted 2 ounces per gallon of water, as well as convenient, 10-ounce bottles, which ensure a proper amount for 5 gallons of usable product
Source: Fiberlock Technologies
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.